For those of you interested in participating in the precisionFDA Gaining New Insights by Detecting Adverse Event Anomalies Using FDA Open Data Challenge, you have one week left to complete your submission. Selected participants will be invited to participate in a panel at the Modernizing FDA’s Data Strategy public meeting. Final submissions are due on February 28th, and providing code is no longer required for a valid entry. Additionally, new guidance is available on the challenge site including updated evaluation criteria and anomaly examples.
We are pleased to announce that the Journal of the American Medical Informatics Association (JAMIA) supports the submission of a paper describing the precisionFDA Gaining New Insights by Detecting Adverse Event Anomalies Using FDA Open Data challenge and broadly applicable insights that emerge from it. Publication in JAMIA will be contingent on a standard evaluation process including editorial assessment and peer review.
If you are interested in learning more about how FDA is modernizing its data strategy, please attend the Modernizing FDA’s Data Strategy public meeting on March 27th. The meeting will also be streamed virtually for those who don’t live in the DC area!
If you have any questions about the challenge, please feel free to post them in this thread and we will respond as quickly as possible.
